Ascendis Pharma A (ASND) Total Current Liabilities (2012 - 2026)
Ascendis Pharma A's Total Current Liabilities was $540.37 million in the quarter ended Jun 30, 2026, down 48.9% from $1.06 billion a year earlier and down 59.0% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Total Current Liabilities (2012 - 2026) Analysis & Trends
As of Dec 31, 2025, Total Current Liabilities at Ascendis Pharma A came in at $1.21 billion, down 13.1% from the prior year.
- Total Current Liabilities shows a five-year compound annual growth rate of 48.3% (years ended Dec 2020 to Dec 2025).
- In earlier years, Total Current Liabilities was $1.39 billion in the year ended Dec 31, 2024 (+74.6%), $796.69 million in the year ended Dec 31, 2023 (-8.5%), $870.98 million in the year ended Dec 31, 2022 (+278.2%) and $230.27 million in the year ended Dec 31, 2021 (+36.9%).
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Total Current Liabilities since the quarter ended Sep 30, 2023.
- Compared with a year earlier, Total Current Liabilities was higher in six of the last eight quarters, with growth averaging 50.3%.
- The best year-over-year quarter for Total Current Liabilities over five years was the quarter ended Jun 30, 2024 (growth of 336.0%); the worst was the quarter ended Jun 30, 2026 (a decline of 48.9%).
- Per Business Quant data, ASND's Total Current Liabilities in the three quarters before the quarter ended Jun 30, 2026 was $1.32 billion (quarter ended Mar 31, 2026), $1.24 billion (quarter ended Dec 31, 2025) and $1.15 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | Ascendis Pharma A | 14.26 Bn | 10.50 Bn | 362.22 Mn | 540.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 540.37 Mn |
| Mar 31, 2026 | 1.32 Bn |
| Dec 31, 2025 | 1.24 Bn |
| Sep 30, 2025 | 1.15 Bn |
| Jun 30, 2025 | 1.06 Bn |
| Mar 31, 2025 | 931.45 Mn |
| Dec 31, 2024 | 1.37 Bn |
| Sep 30, 2024 | 920.81 Mn |
| Jun 30, 2024 | 912.92 Mn |
| Mar 31, 2024 | 867.97 Mn |
| Dec 31, 2023 | 792.44 Mn |
| Sep 30, 2023 | 231.61 Mn |
| Jun 30, 2023 | 209.37 Mn |
| Mar 31, 2023 | 212.91 Mn |
| Dec 31, 2022 | 843.12 Mn |
| Sep 30, 2022 | 144.02 Mn |
| Jun 30, 2022 | 122.85 Mn |
| Mar 31, 2022 | 107.02 Mn |
| Dec 31, 2021 | 230.27 Mn |
| Sep 30, 2021 | 136.94 Mn |
API Access
Ascendis Pharma A Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();